Gordon M Ringold

Title: The Innovations of Gordon M Ringold

Introduction

Gordon M Ringold is a notable inventor based in Palo Alto, CA, with a significant contribution to the field of biotechnology. He holds 5 patents that focus on the production and expression of human interferon in Chinese hamster ovary cells. His work has implications for therapeutic formulations and advancements in medical treatments.

Latest Patents

One of his latest patents involves the production of human interferon-.beta. (IFN-.beta.) in Chinese hamster ovary cells. This innovative process allows for the high-yield production of beta-interferon, which is crucial for various therapeutic applications. Another significant patent details the preparation of DNA constructs that operably link human interferon genes with selective eukaryotic marker genes. This technology enables the expression of human interferon in CHO cells, ensuring that the recombinant interferon produced contains specific glycans found in its native counterpart.

Career Highlights

Throughout his career, Gordon M Ringold has worked with prestigious institutions such as Leland Stanford Junior University and Berlex Laboratories, Inc. His research has contributed to the understanding and application of interferon in medical science, showcasing his expertise in biotechnology.

Collaborations

Gordon has collaborated with notable individuals in his field, including Francis P McCormick and Michael A Innis. These partnerships have furthered his research and innovations in the production of therapeutic proteins.

Conclusion

Gordon M Ringold's contributions to biotechnology, particularly in the production of human interferon, highlight his role as a significant inventor in the field. His patents and collaborations reflect a commitment to advancing medical science through innovative research.